Company Details
| Sector | PHARMACEUTICALS |
| Address | 11-A 11th Floor Sky Tower (East Wing) Dolmen City HC-3 Block 4 Scheme-5 Clifton Karachi 75600 |
| Auditor | M/s KPMG Taseer Hadi & Co. Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi. |
| Website | www.haleon.pk |
| Fiscal Year | December |
| Details |
Details
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance@ 1984 (now Companies Act@ 2017) on 31 March 2015. The Company is a subsidiary of ?Haleon Netherlands B.V?. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing@ marketing and sale of consumer healthcare and over the counter health products.
Company Announcements
| Date/Time | Announcement |
|---|---|
| 23/10/2023 16:08:12 | EPS = 5.36 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 627.355 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,243.835 FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2023 |
| 22/08/2023 15:49:02 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 313.064 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2023 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 726.176 EPS = 2.67 |
| 02/05/2023 12:29:27 | EPS = 2.59 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2023 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 468.104 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 303.139 |
| 15/03/2023 15:43:25 | BOOK CLOSURE TO 27/04/2023 BOOK CLOSURE FROM 20/04/2023 ANNUAL GENERAL MEETING HELD ON 27/04/2023 EPS = 2.78 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 325.411 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 992.791 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2022 |